Skip to main content
. 2021 May 22;20:52. doi: 10.1186/s12944-021-01480-2

Table 2.

Serum lipid profile of participants

Variable Categories Control Benign Breast Disease Breast cancer P-value
Total cholesterol (mg/dL) 187.32 ± 18.93 190.12 ± 15.99 220.40 ± 28.09* < 0.001
≥ 200 15 (30) 16 (32) 39 (78) < 0.001
<  200 35 (70) 34 (68) 11 (22)
Low density lipoprotein cholesterol (mg/ dL) 126.90 ± 15.16 127.44 ± 14.84 142.30 ± 28.43* < 0.001
≥ 130 22 (44) 25 (50) 41 (82) < 0.001
<  130 28 (56) 25 (50) 9 (18)
High-density lipoprotein (mg/ dL) 40.82 ± 6.51 41.14 ± 6.72 39.6 ± 6.98 0.485
<  40 20 (40) 19 (38) 31 (62) 0.032
≥ 40 30 (60) 31 (62) 19 (38)
Triglyceride (mg/dL) 129.28 ± 29.61 130.32 ± 30.15 154.92 ± 48.07* 0.001
≥ 150 8 (16) 9 (18) 26 (52) < 0.001
<  150 42 (84) 41 (82) 24 (48)

Data expressed as n(%) and mean ± SD where appropriate

P-value was determined by Chi-square test and ANOVA with post-hoc analysis by Bonferroni adjustments where appropriate

* P-value significant at < 0.05 level in comparison to control and benign breast disease